12 November 2019
The complementary expertise between healthcare professionals and patients is being increasingly recognized. Patient-partners, as active collaborators, provide added value through their experiential knowledge.
To accomplish its mission of mobilizing research centres around patients’ needs, the Oncopole has recruited 8 people to make up its Patient-Partners Committee. They have shown a great commitment through their care and an ability to share their personal experience. The Patient-Partners Committee was initially mandated to help the Oncopole team define investment priorities that results in a Competition in collaboration with the FRQS. This new funding opportunity is used to fund research projects that are likely to have a positive impact on the experience of cancer patients. This funding program is sponsored by Oncopole in partnership with the FRQS and the Québec Strategy for Patient-Oriented Research (SPOR) Support Unit, and in collaboration with the Programme québécois de cancérologie (PQC) of the Ministère de la Santé et des Services sociaux of Québec.
Priorité Patients Competition
General objective
This competition is seeking to fund research projects that will help improve the services and care provided to cancer patients as well as their quality of life and that of their caregivers. Projects must primarily address one or more of the issues raised by Oncopole patient-partner committee.
Competition total budget : $600 000
Grant amount per project : maximum of $200 000 over 2 years.
Important dates
- Deadline for submitting the Letter of Intent: : September 9, 2019, by 4:30 pm
- Methodology Workshop : during the week of October 7, 2019
- Deadline for submitting the Complete application : December 3, 2019, by 4:30 pm
For more informations, please contact the following persons :
- Oncopole : Maxime Dumais, Project Manager – Oncopole.
- Priorité patient Competition : Manon Pelletier, Program Manager – FRQS.
- Methodology Workshop : Joe Guillame Pelletier, Deputy Director – Québec SPOR support unit.